560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations
S. Crabb, R. Plummer, A. Greystoke, L. Carter, S. Pacey, H. Walter, V.M. Coyle, T. Knurowski, K. Clegg, F. Ashby, N. Pegg, W. West, N. Brooks, A. Hughes, J. de Bono
Research output: Contribution to journal › Meeting Abstract › peer-review
Fingerprint
Dive into the research topics of '560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations'. Together they form a unique fingerprint.